Ayesha Kamal

Ayesha Kamal

Auto-generated profile, based on publicly available information

Ayesha Kamal

Division of Gastroenterology, Johns Hopkins Medical Institutions, Baltimore, MD, United States

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

3 April 2020 in Gut
Verified
Journal Article
Closed access
PDF file
EDEnrique de-Madaria
Enrique de-Madaria
CSClaudia Sánchez-Marin
Claudia Sánchez-Marin
Irene Carrillo MurciaIrene Carrillo Murcia
Irene Carrillo Murcia
SVSanthi Swaroop Vege
Santhi Swaroop Vege
SCSerge Chooklin
Serge Chooklin
JMJosé J Mira
José J Mira
Objective This study aimed to develop and validate a patient-reported outcome measure (PROM) in acute pancreatitis (AP) as an endpoint centred on the patient. Design A PROM instrument (PAtieNt-rePoRted OutcoMe scale in acute pancreatItis, an international proSpEctive cohort study, PAN-PROMISE scale) was designed based on the opinion of patients, professionals and an expert panel. The scale was validated in an international multicentre prospective cohort study, describing the severity of AP and quality of life at 15 days after discharge as the main variables for validation. The COSMIN (COnsensus-based Standards for the selection of health status Measurement INstruments) methodology was applied. Both the design and validation stages considered the content and face validity of this new instrument; the metric properties of the different items, reliability (reproducibility and internal consistence), the construct, structural and criterion validity, responsiveness and interpretability of this scale. Results PAN-PROMISE consists of a seven-item scale based on the symptoms that cause the most discomfort and concern to patients with AP. The validation cohort involved 15 countries, 524 patients. The intensity of symptoms changed from higher values during the first 24 hours to lower values at discharge and 15 days thereafter. Items converged into a unidimensional ordinal scale with good fit indices. Internal consistency and split-half reliability at discharge were adequate. Reproducibility was confirmed using test–retest reliability and comparing the PAN-PROMISE score at discharge and 15 days after discharge. Evidence is also provided for the convergent-discriminant and empirical validity of the scale. Conclusion The PAN-PROMISE scale is a useful tool to be used as an endpoint in clinical trials, and to quantify patient well-being during the hospital admission and follow-up. Trial registration number NCT03650062

1 December 2019 in Pancreatology
Verified
Journal Article
Closed access
VAVenkata Akshintala
Venkata Akshintala
AKAyesha Kamal
Ayesha Kamal
MFMahya Faghih
Mahya Faghih
GCGarry R. Cutting
Garry R. Cutting
LCLiudmila Cebotaru
Liudmila Cebotaru
Vikesh SinghVikesh Singh
Vikesh Singh

1 August 2014 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
PDF file
PSPayal Saxena
Payal Saxena
VSVikesh K. Singh
Vikesh K. Singh
AMAhmed Messallam
Ahmed Messallam
AKAyesha Kamal
Ayesha Kamal
AZAtif Zaheer
Atif Zaheer
MKMouen A. Khashab
Mouen A. Khashab

9 April 2021 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
AAAditya Ashok
Aditya Ashok
MFMahya Faghih
Mahya Faghih
JAJavad R. Azadi
Javad R. Azadi
NPNasim Parsa
Nasim Parsa
CFChristopher Fan
Christopher Fan
Vikesh SinghVikesh Singh
Vikesh Singh

27 March 2025 in Pancreatology
Verified
Journal Article
Closed access
AJArpita Jajoo
Arpita Jajoo
VAViha Atri
Viha Atri
ASAjaya Shrestha
Ajaya Shrestha
OSOmar Ahmed Saad-Ahmed
Omar Ahmed Saad-Ahmed
JVJay Vaidya
Jay Vaidya
VAVenkata Akshintala
Venkata Akshintala